Glenmark Pharmaceuticals board to consider interim dividend, revises record date

Glenmark Pharmaceuticals Limited has announced a revised record date for the potential payment of an interim dividend. Following an intimation dated September 22, 2025, the board of directors is scheduled to convene on Friday, September 26, 2025, to discuss and approve an interim dividend for the financial year 2025-26. Should an interim dividend be declared, the revised record date for its payment will be Friday, October 3, 2025.

This announcement was communicated to both the BSE Limited and The National Stock Exchange of India Ltd. The communication was signed by Harish Kuber, company secretary and compliance officer of Glenmark Pharmaceuticals Limited, on September 22, 2025.

The board meeting will address the possibility of distributing an interim dividend to equity shareholders for the current financial year, 2025-26. Investors should note the revised record date for eligibility if the dividend is approved.